Gemcitabine and CHK1 inhibition potentiate EGFR-directed radioimmunotherapy against pancreatic ductal adenocarcinoma.
about
Targeted radionuclide therapies for pancreatic cancerPerspectives on the combination of radiotherapy and targeted therapy with DNA repair inhibitors in the treatment of pancreatic cancerPrioritizing therapeutic targets using patient-derived xenograft modelsMitochondrial mutations and metabolic adaptation in pancreatic cancer.Radioimmunotherapy--a potential novel tool for pancreatic cancer therapy?Combining Chk1/2 Inhibition with Cetuximab and Radiation Enhances In Vitro and In Vivo Cytotoxicity in Head and Neck Squamous Cell Carcinoma.Potentiation of Peptide Receptor Radionuclide Therapy by the PARP Inhibitor Olaparib.Checkpoint kinase 1 inhibition sensitises transformed cells to dihydroorotate dehydrogenase inhibition.Cancer vaccines and immunotherapeutic approaches in hepatobiliary and pancreatic cancers.Three-dimensional organotypic matrices from alternative collagen sources as pre-clinical models for cell biology.ATR/CHK1 inhibitors and cancer therapy.
P2860
Q26801364-FE46D99D-CDBE-4CB8-B369-274355E3CA86Q28066320-7194A093-4F23-42C4-81B6-F33E298D1FABQ28083993-57AAA278-4BA4-4058-9750-5E0F842C71BBQ37615978-0DFBB106-9E46-4F89-94C9-F1ACE6D024BEQ38450531-C68F5914-D661-48CC-A2F9-31E3DBC4C9D5Q38718745-1AD86577-9586-4AAE-9BCF-D9EF18274E9DQ41211999-34DD6F6A-36B9-4BB6-8C52-B5D749C63A86Q47100853-CC342B55-44DF-467A-BF57-42072F70D0CDQ47109220-AC70E8B3-8CE8-4885-A10C-985C5CC611C5Q47134459-2980CD6E-726C-49CD-B1F9-4FA87FE57E87Q47622968-59130A5A-42B9-4371-86C8-06931529AB19
P2860
Gemcitabine and CHK1 inhibition potentiate EGFR-directed radioimmunotherapy against pancreatic ductal adenocarcinoma.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Gemcitabine and CHK1 inhibitio ...... creatic ductal adenocarcinoma.
@en
type
label
Gemcitabine and CHK1 inhibitio ...... creatic ductal adenocarcinoma.
@en
prefLabel
Gemcitabine and CHK1 inhibitio ...... creatic ductal adenocarcinoma.
@en
P2093
P50
P1476
Gemcitabine and CHK1 inhibitio ...... creatic ductal adenocarcinoma.
@en
P2093
Adnan M Nagrial
Angela Chou
Australian Pancreatic Cancer Genome Initiative
Kum Kum Khanna
Mariska Miranda
Murugan Kalimutho
P304
P356
10.1158/1078-0432.CCR-14-0048
P407
P577
2014-05-16T00:00:00Z